Genetic Analysis directed issue to major shareholders has now been registered with the Norwegian Register of Business Enterprises

REG

On July 1 and July 17, 2024, GA carried out the directed issue that provided the Company with NOK 5.42 million by issuance of 7,225,916 new shares, before issue costs. The direct Issue has now been registered with the Norwegian Register of Business Enterprises.

After this, the Company's new registered share capital is NOK 29,629,962.60 divided into 49,383,271 shares, each with a nominal value of NOK 0.60.

Datum 2024-08-14, kl 08:00
Källa Cision
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!